To determine if gene expression profiling of whole blood cells is a useful source of markers for the early diagnosis of the onset of type 2 diabetes, we examined gene expression profiling of whole blood cells and type 2 diabetes-related organs, such as liver, adipose tissue, and skeletal muscle, of Otsuka Long-Evans Tokushima Fatty (OLETF) rats. At the age of 6 weeks, RNA was isolated from tissues of fasted OLETF and control LongEvans Tokushima Otsuka (LETO) rats. Gene expression was analyzed using the Agilent rat oligo microarray. Gene ontology analysis showed that gene expression of biologically meaningful groups of genes in liver, adipose tissue, and skeletal muscle, which are involved in the pathogenesis of type 2 diabetes, differed between OLETF and LETO rats. Three hundred genes of whole blood cells were differentially expressed. Four out of these 300 genes were related to the insulin-signaling pathway and 57 out of 300 genes were up-or down-regulated in at least one tissues in OLETF rats. These results support our hypothesis that gene expression profiling of whole blood cells might be a useful source of markers to predict the onset of type 2 diabetes.
It is well known that diabetes is one of the most prevalent diseases worldwide. It is estimated that 246 million people have diabetes, and the number is expected to reach 380 million by 2025 (Diabetes Atlas, third edition International Diabetes Federation 2006). Type 2 diabetes accounts for 90-95% of all cases of diabetes, so development of effective treatments is important. There are many treatment modalities such as drugs, exercise therapy, and diet therapy; however, these cures are not effective in all patients because the underlying cause of the disease remains unclear. Type 2 diabetes is caused by many factors, such as multi-genetic factors, obesity, physical inactivity, and unhealthful diet. Therefore, health maintenance and preventive care are greatly needed.
Generally, the onset of type 2 diabetes is judged by measuring the level of fasting glucose and by the results of an oral glucose tolerance test (OGTT) in combination with other clinical parameters. However, the diagnosis of risk prior to the onset of type 2 diabetes is very difficult using these methods, because the phenotypic changes characteristic of type 2 diabetes are not evident during the very early stages of the disease. Therefore, development of a new diagnostic method for predicting the onset of type 2 diabetes would require highly sensitive detection of the progress of disease along with an appraisal of the innate risks such as the genetic factors.
Advances in DNA microarray technology make it possible to monitor thousands of genes using only one assay. 1) Gene expression profiling captures daily changes caused by environmental factors, such as lifestyle, as well as permanent changes caused by structural variations in DNA. Environmental and genetic risks of some diseases can be assessed by pattern recognition of selected gene expression sets. In fact, gene expression signatures are used to predict clinical outcomes and metastatic risks in cancer. 2, 3) Therefore, gene expression in disease-related tissues could be an ideal sample for the identification of signs of the onset of future disease.
To realize accurate risk assessment for the onset of type 2 diabetes, non-invasive methods that evaluate prognostic indicators in readily accessible tissues are needed. Type 2 diabetes-related tissues, such as liver, adipose tissue, and skeletal muscle, are involved in the pathogenesis of type 2 diabetes, but it is difficult to sample these tissues for the purpose of genetic diagnosis in healthy people. Thus, we focused on whole blood cells (WBC), which are easily accessible, for diagnosis. WBC are also an ideal surrogate tissue for use as a diagnostic tool 4) to predict infection, diseases, and other threats, because WBC participate in surveillance of the entire body.
We previously planned the use of gene expression profile in WBC as a diagnostic tool to predict the onset of type 2 diabetes, independent of other research groups. The Otsuka Long-Evans Tokushima Fatty (OLETF) rat is a well-established animal model of spontaneous type 2 diabetes. Because the OLETF rat model is characterized by mild obesity with visceral fat accumulation and late-onset insulin resistance, it resembles human obese patients with type 2 diabetes. 5) Previously, we demonstrated differences in gene expression WBC and liver in OLETF rats prior to the onset of type 2 diabetes and control rats of the same age. 6, 7) In addition, Takamura et al. recently showed that gene expression in blood cells re-flected the pathophysiology of type 2 diabetes patients, supporting our hypothesis. 8) Thus, it is of great interest to identify genes that are differently expressed in both WBC and type 2 diabetes-related tissues, other than liver, before onset of disease.
In the present study, we carried out gene expression analysis of OLETF and Long-Evans Tokushima Otsuka (LETO) rats (control rats) to examine the gene expression profiles in WBC, adipose tissue, and skeletal muscle using oligo microarray. Moreover, we re-examined gene expression in liver because the cDNA microarray that was used in the previous study 7) was unavailable at this time. The results obtained in this study suggest that gene expression profiling of WBC might be a useful source of markers to predict the onset of type 2 diabetes.
MATERIALS AND METHODS

Animals
Male OLETF rats and non-diabetic control male LETO rats (4 weeks of age) were generously provided by the Tokushima Research Institute, Otsuka Pharmaceutical, (Tokushima, Japan). The rats were housed with free access to water and food at 22°C and 58% humidity with light from 7:00 to 19:00. All animal experiments were performed after an overnight fast. All animal procedures were carried out in accordance with the institutional animal care and research advisory committee of the Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Measurements of Plasma Glucose and Insulin When rats reached 6 weeks of age, blood was collected from the tail vein. The glucose concentration in plasma was quantified using the Glucose B Test Kit (Wako Chemical, Osaka, Japan). The insulin concentration in plasma was quantified using the Insulin-Rat T ELISA kit (Shibayagi, Gunma, Japan).
Isolation of Total RNA Total RNA was isolated from liver, adipose tissue, skeletal muscle, and WBC of 6-week old rats. Whole blood was obtained from the carotid artery, adipose tissue was obtained from epididymal fat pads, and skeletal muscle was obtained from the right hindlimb. Total RNA was isolated from WBC using the PAXgene Blood RNA kit protocol (PreAnalytiX, Hombrechtikon, Switzerland). Total RNA was isolated from liver, adipose tissue, skeletal muscle using the TRIzol reagent (Invitrogen, Carlsbad, CA, U.S.A.) and the RNeasy Mini Kit (QIAGEN, Hilden, Germany). Genomic DNA was eliminated using the RNase-free DNase Digest Set (QIAGEN). To avoid differences between individuals, 5 mg of total RNA isolated from four rats were pooled into a single sample. The integrity of the pooled total RNA samples was evaluated using an Agilent 2100 Bioanalyzer (Agilent, Foster City, CA, U.S.A.).
DNA Microarray Experiments 500-ng aliquots of the pooled RNA samples were Cy3-or Cy5-labeled using the Agilent Low RNA Input Fluorescent Linear Amplification Kit (Product No. 5184-3568, Agilent Technologies, Palo Alto, CA, U.S.A.). After checking the labeling efficiency, 1-mg aliquots of Cy3-labeled LETO cRNA and Cy5-labeled OLETF cRNA were mixed and then hybridized to Agilent Rat Oligo Microarrays (G4130A) using the manufacturer's hybridization protocol (Product No. 5184-3568, Agilent Technologies). After the washing step, the microarray slides were analyzed using an Agilent Microarray scanner (G2565AA), using the default settings for all parameters. These experiments were carried out in duplicate using exchanged dye-labeled cRNA probes (i.e., Cy3 and Cy5 dyeswapping experiments). Microarray expression data were obtained using the Agilent Feature Extraction software (Version A.6.1.1), using the default settings for all parameters.
Normalization and Data Analysis A total of 8 samples were analyzed (2 dye-swap samples per each of the 4 different tissues-WBC, liver, adipose tissue, and skeletal muscle). Microarray expression data were imported into GeneSpring GX 7.3 Expression Analysis Software (Agilent Technologies). Three normalization steps were applied as follows: data transformation, dye swap; per spot, divide by control channel; and per chip, normalization to the 50th percentile. Genes were filtered in accordance with the following three criteria; an average raw and control value Ͼ100 in all chips; a present or marginal flag value for both samples in each tissue chip; a percent difference between raw and control values within 51% in each tissue chip. Genes that met all three criteria were extracted. Data analysis focused on these genes, the expression of which changed by 1.5-fold or greater, or less than 0.67-fold, in OLETF rats compared with LETO rats.
Hierarchical Clustering Analysis Gene-tree hierarchical clustering analysis was performed to understand the differential gene expression pattern in diabetes-related tissues. Average linkage was used as the clustering algorithm. Pearson correlations were used as a measure of similarity between the gene expression patterns for each sample. Four subset clusters were identified based on the distance value, which is a measure of similarity.
Gene Ontology Analysis Gene ontology (GO) analysis was performed to assign biological meaning to the subsets of the gene clusters. Overrepresentation of genes with altered expression in OLETF rats compared with LETO rats within specific GO categories was determined using Fisher's exact probability test. GO categories that included more than 10 genes were extracted.
Quantitative Reverse Transcription Polymerase Chain Reaction (PCR) cDNA was prepared from 400-ng aliquots of pooled RNA samples from OLETF and LETO rats using the TaKaRa RNA PCR Kit (AMV) Ver.3.0 (code No. RR019A, TaKaRa, Kusatsu, Japan). The reverse transcription reaction was performed by incubation at 55°C for 30 min, at 99°C for 5 min and at 4°C for 5 min. The resulting cDNA was analyzed by quantitative PCR using the SYBR Green Realtime PCR Master Mix (Code No. QPK-201, 201T, TO-YOBO, Osaka, Japan), except that the primer concentration was 0.2 mM. Gene-specific primer sequences are shown in Table 1 . PCR was performed using the following sequence in an Applied Biosystems 7500 Real Time PCR System: a 10-min pre-incubation at 95°C, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. All samples were run in triplicate. Data were analyzed using the comparative DDCt method and are expressed as relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH), as a reference.
KeyMolnet Software Analysis DNA microarray data were analyzed using KeyMolnet software, which is a new approach to mechanistic analysis, that was developed by the Institute of Medical Molecular Design, Inc. (IMMD).
9)
RESULTS
Characteristics of OLETF Rats before the Onset of Type 2 Diabetes
To confirm the characteristics of OLETF rats before the onset of type 2 diabetes, body weight and fasting plasma glucose and insulin concentrations were measured. The measurements of fasting plasma glucose and insulin concentrations are commonly used methods to judge the onset of type 2 diabetes. As shown in Table 2 , the body weight of OLETF rats was slightly greater than that of LETO rats, but the difference was not significant ( pϭ0.053). Fasting plasma glucose and insulin concentrations were not significantly different between OLETF and LETO rats (pϭ 0.255, 0.185, respectively). Also, results of the glucose tolerance test (GTT) did not differ between OLETF and LETO 5-and 8-weeks-old rats, as described previously. 7) These results show that a new diagnostic method is needed to predict the onset of type 2 diabetes.
Microarray Analysis of Gene Expression Profiles in Diabetes-Related Tissues
We next focused on global gene expression in diabetes-related tissues, such as liver, adipose tissue, and skeletal muscle, which are expected to express early symptoms of type 2 diabetes. We hypothesized that gene expression in diabetes-related tissues would identify signs of diabetes earlier than serum parameters, as described in the above section. Plots of cRNA signal intensity for LETO and OLETF rats showed a widely scattered pattern in each tissue (Fig. 1 ). In particular, the pattern in adipose tissue exhibited the widest scattering. In the liver, 503 genes had expression ratios that were at least 1.5-fold higher or lower in OLETF than in LETO rats (401 genes were up-regu- The value of body weight and fasting plasma glucose were expressed as meansϮS.D. (nϭ6) and the value of fasting plasma insulin were expressed as meansϮS.D. (nϭ3). Three parameters were not significant (pϽ0.05) between LETO and OLETF rats. For each spot, the cRNA intensity signal for LETO was plotted against that for OLETF on a logarithmic scale. The value of LETO (or OLETF) cRNA intensity signal on each spot was the average value of Cy3-labeled LETO (or OLETF) cRNA intensity and Cy5-labeled LETO (or OLETF) cRNA intensity. Pink spots indicate that the gene expression ratio of OLETF to LETO was greater than 1.5 or less than 0.67. lated and 102 genes were down-regulated). In adipose tissue, 1432 genes had significant differences in expression ratio (944 genes were up-regulated and 488 genes were down-regulated). In skeletal muscle, the expression of 314 genes was significantly altered in OLETF rats compared with LETO rats. (256 genes were up-regulated and 58 genes were downregulated). Figure 2 shows hierarchical clustering analysis of the 2025 genes, for which the expression ratio in OLETF rats was 1.5-fold greater or less than that in LETO rats in at least one tissue. To characterize gene expression patterns among these tissues, 4 subset clusters were identified based on the distance value, which is a measure of similarity. Cluster 1 included 562 genes, which were characterized as high-expression in the liver of OLETF rats. Cluster 2 included 558 genes, which were characterized as low-expression in adipose tissue of OLETF rats. Cluster 3 included 136 genes which were characterized low expression in liver and high expression in adipose and skeletal muscle of OLETF rats. Cluster 4 included 769 genes, which were characterized as high-expression in adipose tissue of OLETF rats. To assign biological meaning to these clusters, gene ontology (GO) analysis was performed. GO can be defined by three aspects; molecular function, biological process, and cellular components. In this analysis, GO was defined by biological process. Classifications using GO terms for each cluster are shown in Table 3 . Among the expression levels of the top 100 genes that are preferentially expressed in LETO and OLETF in liver, adipose tissue, and skeletal muscle, Cluster 1 included Lpin2 [10] [11] [12] and Ucp3, 13, 14) which are related to the progress of diabetes. In particular, Ucp3 is involved in lipid metabolism (GO:6629). Cluster 2 includes five genes Hepattic protein EIIH, 15) Nr4a3, 16) Adrb3, [17] [18] [19] [20] Adiponectin, 21) and Rbp4. 22, 23) In particular, Nr4a3 and Adrb3 genes were involved in responses to stimulus (GO:50896), and Adiponectin genes were involved in lipid metabolism (GO:6629). Cluster 3 included the IGFBP2 gene, 24, 25) however, there were no statistically overrepresented genes (more than 10 genes) within a specific GO term (pϽ0.01). Cluster 4 included the Pla2g7 26) gene, which was not assigned a GO term. These specific genes are involved in the pathogenesis of type 2 diabetes, therefore, they are covered in detail in the discussion section. These results suggest that gene expression in type 2 diabetes-related tissues is sensitive to the progress of type 2 diabetes before changing serum parameters.
Three-Hundred Genes Were Differentially Expressed in WBC As revealed by GO analysis and literature research, it might be possible to detect pre-clinical signs of type 2 diabetes by use of groups of gene expression in diabetes-related tissues. However, it is unethical to obtain tissue 1036 Vol. 33, No. 6
Fig. 2. Hierarchical Clustering Analysis of Differentially Expressed Genes in Diabetes-Related Tissues
2025 genes with an expression ratio of LETO to OLETF is greater than 1.5 or less than 0.67 in at least 1 tissue are shown. Red and green represent preferential expression in OLETF and LETO rats, respectively. Black represents equivalent expression in OLETF and LETO rats. In 2025 genes, 4 subset clusters were identified based on the distance value, which is a measure of similarity. The condition of Scatter plot for WBC is the same as Fig. 1 . KeyMolnet software extracted 4 genes related to the insulin-signaling pathway from 300 genes with expression ratios of OLETF to LETO greater than 1.5 or less than 0.67 in whole blood cells. Red indicates up-regulated genes, whereas blue indicates down-regulated genes. PC-1, ectonucleotide pyrophosphatase/phosphodiesterase 1; SIRP, signal-regulatory protein alpha; Grb2, growth factor receptor bound protein 2; Pten, phosphatase and tensin homolog.
biopsies for the purpose of early diagnosis in healthy people. To realize early diagnosis of type 2 diabetes, easily accessible tissues are needed. Then we focused on the gene expression profile of WBC. In WBC, expression of 300 genes in OLETF rats was at least 1.5-fold greater or less than expression in LETO rats (Fig. 3a) . This result suggests that gene expression in WBC could be used to diagnose type 2 diabetes prior to the onset of the disease, as fasting glucose and insulin concentrations and GTT are not significantly changed early in the pathogenesis of diabetes. However, the functional associations of the 300 genes were unknown. Therefore, KeyMolnet software was used to determine if some genes were related by function or pathway. As shown in Fig. 3b, 4 genes are involved in the insulin-signaling pathway. Quantitative RT PCR analysis of the 4 genes showed similar expression profiles, which was confirmed by the microarray data (Fig. 4) . These results suggest an active insulin signal pathway in whole blood cells, and that insulin resistance begins at the transcriptional level.
Fifty-Seven Genes in WBC Were Concurrently Expressed in Diabetes-Related Tissues In the above section, 4 genes in whole blood cells are involved in the insulin-signaling pathway. The PC-1 (ectonucleotide pyrophosphatase/ phosphodiesterase 1) gene was among those that also were Genes in list in category were the number of genes which were classified with statistically overrepresented GO term. GO terms with biological process were shown. GO, Gene ontology. upregulated in adipose tissue ( Table 4 ). The PC-1 gene is associated with type 2 diabetes, [27] [28] [29] therefore, we hypothesized that some of the genes exhibited an altered expression in diabetes-related tissues and could be detected in WBC. A total of 57 genes were detected in WBCs: 25 genes (14 genes were up-regulated, 7 genes were down-regulated) in liver, 41 genes (15 genes were up-regulated, 25 genes were down-regulated) in adipose tissue, and 14 genes (11 genes were upregulated, 3 genes were down-regulated) in skeletal muscle (Table 4) . To validate the microarray results, quantitative RT PCR analyses were performed. As shown in Fig. 5 , gene expression of the 10 selected genes showed a similar expression profile, which was consistent with the microarray data. Among the 57 genes, FABP5, 30, 31) Cfd, 32,33) PC-1, [27] [28] [29] and Ucp3 13, 14) were reported to be associated with the progress of type 2 diabetes. Possible interpretations of these results are discussed in the last section.
DISCUSSION
The results of the present study demonstrate that the gene expression profile of WBC might be useful for detection of pre-clinical symptoms of type 2 diabetes in OLETF rats. To the best of our knowledge, this is the first report of screening WBC candidate genes, which are also up-or down-regulated in adipose tissue or skeletal muscle.
Fasting plasma glucose and insulin concentrations and, the glucose tolerance test (GTT) were not significantly different between OLETF and LETO rats ( Table 2, ref. 7) . These results suggest that another diagnostic method is needed to detect type 2 diabetes during the very early stage. In contrast, dramatic alternations in gene expression were seen in liver, adipose tissue and skeletal muscle prior to the onset of type 2 diabetes (Figs. 1, 2) . For example, the IGFBP2 (insulin-like growth factor binding protein 2) gene in liver was down-regulated (0.53 fold) in OLETF rats. I have previously mentioned that IGFBP2 gene expression is much lower (about 10 times) in the liver of OLETF rats. 25) Heald et al. showed that a lower concentration of IGFBP2 in serum is a marker for elevating serum fasting glucose in patients with type 2 diabetes. 24) Therefore, these results suggest that lower IGFBP2 in serum might be influenced by lower IGFBP2 gene expression in the liver.
In adipose tissue, the Pla2g7 (phospholipase A2, group 7) gene was up-regulated (3.3 fold) in OLETF rats, which was also up-regulated in obese Pima Indians in microarray and Quantitative RT-PCR analysis. 26) Pima Indians are believed to be a genetic high-risk group for developing obesity, insulin resistance, and type 2 diabetes. Therefore, there is some possibility that the progress of these symptoms begins in adipose tissue at an early stage.
In skeletal muscle, Adiponectin and Rbp4 genes were both up-regulated (2.5 fold) in OLETF rats. Adiponectin is expressed at the mRNA and protein levels in skeletal muscle of ob/ob mice. 21) This is viewed as a result of lipotoxicity and related oxidative stress. On the other hand, Rbp4 (retinolbinding protein 4) expression in skeletal muscle correlates highly with both insulin resistance (Graham et al. the 67th annual meeting of the American Diabetes Association Scientific Sessions 2007) and an increase in body fat percentage, as does adiponectin mRNA expression. 22) Therefore, it is suggested that insulin resistance and lipotoxicity begins in skeletal muscle.
These changes of gene expression in three tissues suggests that type 2 diabetes is progresses gradually in liver, adipose Black and open bars represents each gene expression ratios of OLETF to LETO on a log10 scale in the microarray and quantitative RT-PCR experiments, respectively. cDNA was prepared from 400-ng aliquots of each total WBC RNA sample obtained from LETO and OLETF rats. The levels of each transcript were measured using an SYBR green real time PCR system. The GAPDH transcript was used to adjust the amount of transcript in LETO and OLETF. PC-1, ectonucleotide pyrophosphatase/ phosphodiesterase 1; SIRP, signal-regulatory protein alpha; Grb2, growth factor receptor bound protein 2; Pten, phosphatase and tensin homolog. The value of expression level in LETO and OLETF is the arithmetical average of LETO (or OLETF) cRNA intensity in two chips, and the ratio is the geometric average of two chips.
tissue, and skeletal muscle before changing serum parameters. However, it is unethical to obtain tissue biopsies for the purpose of early diagnosis in healthy people. Therefore, we focused on gene expression in WBC, which contact all tissues, including liver, adipose tissue, and skeletal muscle. WBC directly reflect the conditions of the liver, adipose tissue, and skeletal muscle so that the continuous interaction among WBC and these tissues gives rise to the possibility that gene expression in WBC might be a sensitive diagnostic indicator to catch the changes of these tissues. The results shows that 300 genes were up-or down-regulated in OLETF rats (Fig. 3a) , and 57 genes were concurrently expressed in WBCs, liver, adipose tissue, and skeletal muscle in OLETF rats (Table 4) . Borovecki et al. showed the utility of the some genes whose expression is altered at the transcriptional level in common in WBC and the brain as biomarkers for Huntington's disease. 27) Therefore, concurrently expressed genes in WBC and diabetes-related tissues could be a diagnostic marker for type 2 diabetes.
For example, PC-1 gene was up-regulated in WBC and Adipose tissue (Fig. 5 ). PC-1 is an inhibitor of insulin receptor tyrosine kinase activity, and is involved in the pathogenesis of insulin resistance in type 2 diabetes. [28] [29] [30] The activity of PC-1 in lymphocytes, which are a type of WBC, was increased in type 2 diabetes patients. 28) On the other hand, increased PC-1 protein in adipose tissue was associated with whole-body insulin resistance in healthy non-obese subjects. 29) These results suggest that monitoring mRNA expression of the PC-1 gene in WBC and adipose tissue might help predict the onset of type 2 diabetes and its mRNA expression of adipose tissue. The FABP5 (fatty acid binding protein 5) gene was up-regulated in WBCs and liver, and down-regulated in adipose tissue (Fig. 5 ) and is involved in the pathogenesis of obesity-related insulin resistance and type 2 diabetes. 31) In macrophage, depletion of FABP4 and FABP5 led to enhanced insulin signaling and glucose uptake in adipocytes. 32) This phenomenon is very interesting because gene expression in macrophage, as a part of WBC, affects the function of adipocyte, and is a powerful supporter of the usefulness of gene expression in WBCs.
There are some reports indicating the utility of blood gene expression as a potential diagnostic tool. Hayashi et al. showed that several type 2 diabetes-related genes were up-or down-regulated in both WBC and liver after the onset of type 2 diabetes. 25) Takamura et al. showed that c-Jun terminal kinase (JNK) and mitochondrial oxidative phosphorylation (OXPHOS) pathways of peripheral blood mononuclear cells (PBMCs) could be used as surrogate transcriptional markers in type 2 diabetes patients. 8 ) Liew et al. showed that the peripheral blood transcriptome was a potential diagnostic tool and approximately 80% of genes expressed in any of nine human tissues were also found expressed in blood cells. 4) These results strongly suggest that blood gene expression provides useful information for whole-body analysis. However, the influence of gene expression in WBCs on the onset of type 2 diabetes is unclear at this time. Therefore, the usefulness should become clear as the relationship between gene expression in WBCs and disease is better understood.
In summary, blood gene expression profiling is useful for markers predicting type 2 diabetes at an very early stage. The results of the present study will advance our progress towards diagnosis of type 2 diabetes.
